Yanbin Zhou Selected Research

Yanbin Zhou Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 09/2009
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2015
6	Lung Neoplasms (Lung Cancer) 07/2023 - 09/2009
4	Neoplasm Metastasis (Metastasis) 06/2021 - 04/2010
2	Hypoxia (Hypoxemia) 06/2021 - 05/2021
2	Breast Neoplasms (Breast Cancer) 06/2021 - 01/2014
2	Adenocarcinoma of Lung 01/2017 - 01/2014
2	Stomach Neoplasms (Stomach Cancer) 08/2015 - 09/2009
2	Carcinoma (Carcinomatosis) 08/2015 - 09/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2023
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2023
1	Pneumonia (Pneumonitis) 05/2023
1	Pleural Effusion (Pleural Effusions) 05/2023
1	Emphysema 05/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2023
1	Cross Infection (Nosocomial Infection) 01/2022
1	COVID-19 09/2021
1	Medium chain acyl CoA dehydrogenase deficiency 08/2021
1	VLCAD deficiency 08/2021
1	Short chain Acyl CoA dehydrogenase deficiency 08/2021
1	Fatigue 08/2021
1	Hypoglycemia (Reactive Hypoglycemia) 08/2021
1	Melanoma (Melanoma, Malignant) 12/2020
1	Tertiary Lymphoid Structures 12/2020
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Fever (Fevers) 08/2015
1	Chronic Periodontitis 11/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2008
1	Cachexia 01/2008

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 09/2021 - 09/2009
4	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2014
3	Messenger RNA (mRNA)IBA 04/2021 - 09/2009
3	icotinibIBA 10/2015 - 07/2015
2	Immune Checkpoint InhibitorsIBA 05/2023 - 01/2019
2	CytokinesIBA 09/2021 - 01/2014
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2021 - 05/2021
2	Matrix Metalloproteinases (MMPs)IBA 10/2018 - 01/2014
2	Indicators and Reagents (Reagents)IBA 10/2016 - 01/2014
1	Hemoglobins (Hemoglobin)IBA 07/2023
1	hemoglobin ASIBA 07/2023
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	Lactose FDA LinkGeneric 01/2022
1	Nucleic AcidsIBA 09/2021
1	Systemic carnitine deficiencyIBA 08/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 08/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 08/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2021
1	SolutionsIBA 06/2021
1	Sirolimus (Rapamycin)FDA Link 06/2021
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 06/2021
1	AntioxidantsIBA 05/2021
1	Adenosine Triphosphate (ATP)IBA 05/2021
1	Glucose (Dextrose)FDA LinkGeneric 05/2021
1	Glutathione (Reduced Glutathione)IBA 05/2021
1	HLA-A Antigens (HLA-A)IBA 12/2020
1	HLA-B Antigens (HLA-B)IBA 12/2020
1	Diphosphonates (Bisphosphonates)IBA 11/2019
1	Tyrosine Kinase InhibitorsIBA 11/2019
1	NivolumabIBA 01/2019
1	Carcinoembryonic AntigenIBA 02/2018
1	ErbB Receptors (EGF Receptor)IBA 02/2018
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2018
1	Tigecycline (Tygacil)FDA Link 01/2018
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 09/2017
1	Protons (Proton)IBA 09/2017
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2016
1	TensinsIBA 10/2016
1	A-Form DNA (A-DNA)IBA 01/2014
1	InterleukinsIBA 01/2014
1	AGRO 100IBA 01/2014
1	LigandsIBA 01/2014
1	Nanoparticle Drug Delivery SystemIBA 01/2014
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2014
1	NF-kappa B (NF-kB)IBA 01/2014
1	NucleolinIBA 01/2014
1	Cyclin B1IBA 01/2012
1	Extracellular Matrix ProteinsIBA 04/2010
1	Cysteine (L-Cysteine)FDA Link 04/2010
1	matrigelIBA 04/2010
1	Small Interfering RNA (siRNA)IBA 09/2009
1	Cyclin D1IBA 09/2009
1	Kruppel-Like Factor 4IBA 09/2009
1	Interleukin-6 (Interleukin 6)IBA 01/2008

Therapy/Procedure

5	Immunotherapy 05/2023 - 01/2014
2	Photochemotherapy (Photodynamic Therapy) 06/2021 - 05/2021
2	Intravenous Injections 06/2021 - 05/2021
2	Therapeutics 05/2021 - 02/2018
1	Radiotherapy 05/2023
1	Fat-Restricted Diet (Diet, Fat Restricted) 08/2021
1	Photothermal Therapy 06/2021
1	Lasers (Laser) 06/2021
1	Phototherapy (Light Therapy) 06/2021
1	Conversion to Open Surgery 08/2015
1	Length of Stay 08/2015
1	Gastrectomy 08/2015
1	Debridement 11/2010